Fundamentals of drug design from a biophysical viewpoint
- 1 December 1994
- journal article
- review article
- Published by Cambridge University Press (CUP) in Quarterly Reviews of Biophysics
- Vol. 27 (4) , 435-481
- https://doi.org/10.1017/s0033583500003103
Abstract
Drug design means many things to many people. Commercially the aim is the development of compounds that can be patented and meet a variety of regulatory standards. In drug design, for medical purposes, toxicity and bio-availability are major considerations.Keywords
This publication has 96 references indexed in Scilit:
- When Are Free Energy Components Meaningful?The Journal of Physical Chemistry, 1994
- A Structure Refinement Method Based on Molecular Dynamics in Four Spatial DimensionsJournal of Molecular Biology, 1993
- An Effective Solvation Term Based on Atomic Occupancies for Use in Protein SimulationsMolecular Simulation, 1993
- Prediction of the activity and stability effects of site-directed mutagenesis on a protein coreJournal of Molecular Biology, 1992
- Inclusion of Thermal Motion in Crystallographic Structures by Restrained Molecular DynamicsScience, 1990
- Time-dependent distance restraints in molecular dynamics simulationsChemical Physics Letters, 1989
- A geometric approach to macromolecule-ligand interactionsJournal of Molecular Biology, 1982
- A New Substituent Constant, π, Derived from Partition CoefficientsJournal of the American Chemical Society, 1964
- p-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical StructureJournal of the American Chemical Society, 1964
- The Correlation of Biological Activity of Plant Growth Regulators and Chloromycetin Derivatives with Hammett Constants and Partition CoefficientsJournal of the American Chemical Society, 1963